Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Behrooz Kasraee"'
Publikováno v:
Health Science Reports, Vol 7, Iss 2, Pp n/a-n/a (2024)
Abstract Background Solar lentigines are common hyperpigmented lesions typically appearing after 50 years of age and associated with negative psychological effects in affected individuals. Topical depigmenting products, such as hydroquinone and even
Externí odkaz:
https://doaj.org/article/87b9ce3ff81942bda5bbda6c06c4a40f
Autor:
Behrooz Kasraee
Publikováno v:
Pigmentation Disorders-Etiology and Recent Advances in Treatments
Pigmentation Disorders-Etiology and Recent Advances in Treatments ISBN: 9781803568997
Pigmentation Disorders-Etiology and Recent Advances in Treatments ISBN: 9781803568997
Skin hyperpigmentary disorders are frequent and psychologically disturbing conditions for patients. Skin depigmenting agents have been widely used for the treatment of such disorders. The most efficacious depigmenting agents, such as hydroquinone and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::419b81f5130ab9de140a02fb0c8b759d
https://mts.intechopen.com/articles/show/title/skin-depigmenting-agents-where-do-we-stand-
https://mts.intechopen.com/articles/show/title/skin-depigmenting-agents-where-do-we-stand-
Publikováno v:
Journal of cosmetic dermatologyREFERENCES. 21(7)
Few safe and effective treatments are available for melasma. Cysteamine, a non-melanocytotoxic molecule is a safer alternative to hydroquinone and usable for long-term use.To evaluate the effect of cysteamine 5% cream in the treatment of melasma.Sixt
Publikováno v:
Journal of Dermatological Treatment. 29:182-189
Background: Melasma is a difficult-to-treat hyperpigmentary disorder. Very few studies have been performed regarding the efficacy of cysteamine in the treatment of melasma.Objective: To determine the efficacy of cysteamine cream in the treatment of p
Publikováno v:
Journal of cosmetic dermatology. 18(1)
L-Cysteamine is a biological antioxidant produced during the coenzyme A metabolism cycle and is naturally present in all mammalian cells. The efficacy of topical cysteamine for the treatment of melasma has been recently shown in two double-blind, ran
Publikováno v:
Open Drug Discovery Journal, Vol. 3 (2014) pp. 1-9
In spite of the numerous depigmenting agents available, there is an inverse relationship between safety and efficiency. Natural retinoids exert depigmenting activities in vivo, but have a narrow therapeutic window. There is thus a need for a new clas
Ebselen is a new skin depigmenting agent that inhibits melanin biosynthesis and melanosomal transfer
Autor:
Lionel Fontao, Vincent Piguet, Gholamhossein Ranjbar Omrani, Denis Salomon, Pierre Carraux, Behrooz Kasraee, Jean-Hilaire Saurat, Olivier Sorg, Damjan S. Nikolic
Publikováno v:
Experimental Dermatology. 21:19-24
We assessed the ability of ebselen, a glutathione peroxidase mimic, to reduce pigmentation in various models. In murine B16 melanocytes, 25 μm ebselen inhibited melanogenesis and induced a depolymerisation of actin filaments. In co-cultures of B16 m
Autor:
Behrooz Kasraee, Damjan S. Nikolic, Marcela Pataky, Denis Salomon, Jean-Hilaire Saurat, Vincent Piguet, Olivier Sorg, Pierre Carraux
Publikováno v:
Experimental Dermatology. 20:938-942
Three major difficulties must be overcome to establish a quantitative method for melanosomal transfer analysis: (i) establishing a three-dimensional co-culture reassuring direct melanocyte to keratinocyte transfer, (ii) separation of melanocytes and
Autor:
Jean-Hilaire Saurat, G.H. Safaee Ardekani, Gholamhossein Ranjbar Omrani, Behrooz Kasraee, Farhad Handjani, M. Nikbakhsh, A. Parhizgar, M. Samani, Ahad Eshraghian, Olivier Sorg, Nader Tanideh
Publikováno v:
Skin Pharmacology and Physiology. 21:300-305
Methimazole is an oral antithyroid compound that exhibits a skin-depigmenting effect when used topically. However, the effect of topical methimazole on thyroid function has not been reported. This study was aimed at assessing the safety of topical me
Autor:
M. Ploch, Ulrike Blume-Peytavi, Joachim W. Fluhr, Juergen Lademann, D. Paganuzzi, Daniela Monti, Jonathan Hadgraft, Ahad Eshraghian, A. Parhizgar, M. Nikbakhsh, Alexa Patzelt, Valentine M. Gelikonov, Jean-Hilaire Saurat, Heike Richter, J. du Plessis, Johann W. Wiechers, Nader Tanideh, Wolfram Sterry, Silvia Tampucci, S A Gonchukov, Jürgen Lademann, Susi Burgalassi, Juliane Reuter, H. Scheuvens, Olivier Sorg, A.M. Sergeev, C.R. Fortenbach, G.H. Safaee Ardekani, Howard I. Maibach, Farhad Handjani, Christoph M. Schempp, M. Samani, C. Huyke, Bobeck S. Modjtahedi, N.D. Gladkowa, Patrizia Chetoni, Thilo Jakob, K. Neumann, J. Shevtsova, A. Ghirardini, Behrooz Kasraee, C.L. Kelly, Anja Otto, I Brini, Gholamhossein Ranjbar Omrani
Publikováno v:
Skin Pharmacology and Physiology. 21:I-IV